A test kit (Iso-ALP, Boehringer Mannheim) for measuring human bone alkaline phosphatase activity in serum or plasma was evaluated in five laboratories in three countries. The assay is based on the principle described by Rosalki and Foo (Gun Chem 1984;30: 1182-6) and uses wheat germ lectin to precipitate bone alkaline phosphatase. Residual ALP in the supernate in comparison with total ALP is used to quantify the bone fraction. 
A test kit (Iso-ALP, Boehringer Mannheim) for measuring human bone alkaline phosphatase activity in serum or plasma was evaluated in five laboratories in three countries. The assay is based on the principle described by Rosalki and Foo (Gun Chem 1984;30: 1182-6) and uses wheat germ lectin to precipitate bone alkaline phosphatase. Residual ALP in the supernate in comparison with total ALP is used to quantify the bone fraction. The imprecision of residual ALP measurement was low (median between-run CV 4.9%) and comparable with that of total ALP. Unearity of precipitation was demonstrable up to a bone ALP activity (diethanolamine buffer 37#{176}C) of 2000 U/L, though a matrix effect was observed for dilutions of high-activity sera in saline or bovine serum albumin.
For 389 ( Comparison with electrophoresis method. Figure  2 shows bone ALP might yield bone ALP activity that apparently exceeds that for total ALP (see Figure 3) . This situation, though rare, may be encountered with cord-blood sera and plasma samples from infants. In both, ALP is almost exclusively of bone origin and, particularly in the former, >95% of bone ALP may be precipitated.
Materials and Methods
We therefore recommend that for samples with <10% residual activity, the bone ALP activity be equated with that for total ALP. 
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